author-photo

E. Fogarty

44

Papers

291

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Comparative Analysis Of Health Technology Assessments Of Drugs For The Treatment Of Multiple Myeloma

2017 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.

2016 Multiple sclerosis and related disorders
Show All
- Source
- Cite
- Save
Citations (69)
Direct costs of interferon‐based and interferon‐free direct‐acting antiviral regimens for the treatment of chronic hepatitis C infection

2016 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (5)
A Review Of The Quality And Accuracy Of Budget Impact Models For High Cost Drugs In Ireland

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
The payer’s perspective: What is the burden of MS and how should the patient’s perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?

2016 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (15)
Health Systems in Transition. Pharmaceutical regulation in 15 European countries: review.

2016
Show All
- Source
- Cite
- Save
Citations (5)
Ranking of Disease-Modifying Therapies for Multiple Sclerosis.

2015 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland

2014 Applied Health Economics and Health Policy
Show All
- Source
- Cite
- Save
Citations (20)
Predicted Versus Actual Budget Impact of High-Cost Drugs In Ireland

2014 Value in Health
- E. Fogarty
- Michael J. Barry
Show All
- Source
- Cite
- Save
Citations (0)
Comparing the Efficacy of First and Second Generation Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis

2013 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)